États-Unis · Agences & temps réel · Business Wire

Sumitomo Pharma America to Present New Clinical Data on Enzomenib and Nuvisertib at the 2026 American Society of Hematology Annual Meeting

Publié par Business Wire · États-Unis il y a 15 h

– SMPA to present first data from ongoing Phase 2 clinical trial of enzomenib in patients with relapsed or refractory acute leukemia, with KMT2A rearrangements, an aggressive…

Lire l'article complet sur Business Wire Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.businesswire.com)

Sumitomo Pharma America to Present New Clinical Data on Enzomenib and Nuvisertib at the 2026 American Society of Hematology Annual Meeting

À lire aussi

Bangladesh garment factories close as workers clash with police in pay protests

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot

Sumitomo Pharma America to Present New Clinical Data on Enzomenib and Nuvisertib at the 2026 American Society of Hematology Annual Meeting

Partager

À lire aussi

Bangladesh garment factories close as workers clash with police in pay protests

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot